Yiguo Hu

6.1k total citations
89 papers, 3.1k citations indexed

About

Yiguo Hu is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Yiguo Hu has authored 89 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Hematology, 45 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Yiguo Hu's work include Multiple Myeloma Research and Treatments (23 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Protein Degradation and Inhibitors (18 papers). Yiguo Hu is often cited by papers focused on Multiple Myeloma Research and Treatments (23 papers), Chronic Myeloid Leukemia Treatments (23 papers) and Protein Degradation and Inhibitors (18 papers). Yiguo Hu collaborates with scholars based in United States, China and Sweden. Yiguo Hu's co-authors include Shaoguang Li, Cong Peng, Kenneth C. Anderson, Paul G. Richardson, Yu‐Tzu Tai, Richard A. Van Etten, Yaoyu Chen, Haojian Zhang, Y Chen and Nikhil C. Munshi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Nature Genetics.

In The Last Decade

Yiguo Hu

82 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yiguo Hu United States 25 1.7k 1.5k 805 772 365 89 3.1k
Antoninus Soosaipillai Canada 38 1.3k 0.8× 877 0.6× 1.8k 2.3× 1.1k 1.4× 227 0.6× 91 3.6k
Sonia Vallet United States 31 1.8k 1.1× 1.4k 0.9× 322 0.4× 1.5k 1.9× 97 0.3× 104 3.3k
Hitesh Patel United Kingdom 22 1.1k 0.7× 622 0.4× 333 0.4× 367 0.5× 92 0.3× 44 2.3k
Andrew A. Lane United States 24 2.2k 1.3× 1.0k 0.7× 355 0.4× 1.2k 1.6× 43 0.1× 109 4.0k
Kimberly Straley United States 16 1.3k 0.8× 358 0.2× 470 0.6× 366 0.5× 174 0.5× 25 3.1k
Jean‐Baptiste Telliez United States 28 1.2k 0.7× 274 0.2× 237 0.3× 807 1.0× 544 1.5× 36 2.9k
Daniela Ungureanu Finland 23 1000 0.6× 274 0.2× 479 0.6× 886 1.1× 97 0.3× 51 2.1k
Athos Gianella-Borradori Switzerland 22 968 0.6× 304 0.2× 267 0.3× 883 1.1× 111 0.3× 52 2.5k
Enrique M. Ocio Spain 41 2.7k 1.6× 2.6k 1.8× 1.4k 1.7× 1.9k 2.5× 64 0.2× 206 5.2k

Countries citing papers authored by Yiguo Hu

Since Specialization
Citations

This map shows the geographic impact of Yiguo Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yiguo Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yiguo Hu more than expected).

Fields of papers citing papers by Yiguo Hu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yiguo Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yiguo Hu. The network helps show where Yiguo Hu may publish in the future.

Co-authorship network of co-authors of Yiguo Hu

This figure shows the co-authorship network connecting the top 25 collaborators of Yiguo Hu. A scholar is included among the top collaborators of Yiguo Hu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yiguo Hu. Yiguo Hu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Bin, et al.. (2025). A novel strategy for preparation of residual oil-based porous carbon microspheres: Molecular pre-crossing and chemical activation method. Colloids and Surfaces A Physicochemical and Engineering Aspects. 715. 136670–136670. 3 indexed citations
2.
Hu, Yiguo, et al.. (2025). Efficient and rapid removal of thiophene sulfides from fuel using zirconia-loaded phosphotungstic acid. RSC Advances. 15(21). 16532–16539. 1 indexed citations
5.
Hu, Yiguo, Wei Chen, Ming Yu, et al.. (2025). Valorizing wood waste into high-performance hierarchical porous carbon absorbers with tailored electromagnetic properties. Applied Surface Science. 720. 165302–165302.
7.
Hu, He-Ping, Lijia Yu, Zhao Ding, et al.. (2023). Chemo–immunotherapy for chemo-resistance and metastasis of triple-negative breast cancer by combination of iron-oxide nanoparticles and dual-targeting doxorubicin liposomes. Chinese Chemical Letters. 34(10). 108592–108592. 11 indexed citations
8.
Hu, Yiguo, et al.. (2023). Therapeutic potential of a synthetic dual JAK1/TYK2 inhibitor in inflammatory bowel disease. International Immunopharmacology. 126. 111238–111238. 7 indexed citations
9.
Qiu, Qiang, Yuanyuan Sun, Qingqing Li, et al.. (2023). TSPAN32 suppresses chronic myeloid leukemia pathogenesis and progression by stabilizing PTEN. Signal Transduction and Targeted Therapy. 8(1). 90–90. 6 indexed citations
10.
Qiu, Qiang, Minghai Tang, Fang Wang, et al.. (2019). Purinostat Mesylate Is a Uniquely Potent and Selective Inhibitor of HDACs for the Treatment of BCR-ABL –Induced B-Cell Acute Lymphoblastic Leukemia. Clinical Cancer Research. 25(24). 7527–7539. 16 indexed citations
11.
Wang, Fang, Li Zheng, Zhuang Yang, et al.. (2018). SKLB-23bb, A HDAC6-Selective Inhibitor, Exhibits Superior and Broad-Spectrum Antitumor Activity via Additionally Targeting Microtubules. Molecular Cancer Therapeutics. 17(4). 763–775. 21 indexed citations
12.
Li, Ning, Yeming Yang, Qiang Qiu, et al.. (2018). Tmem30a Plays Critical Roles in Ensuring the Survival of Hematopoietic Cells and Leukemia Cells in Mice. American Journal Of Pathology. 188(6). 1457–1468. 20 indexed citations
13.
Li, Xiaoguang, Zhihao Wang, Lu Tan, et al.. (2017). Correcting miR92a-vGAT-Mediated GABAergic Dysfunctions Rescues Human Tau-Induced Anxiety in Mice. Molecular Therapy. 25(1). 140–152. 43 indexed citations
14.
Zhao, Jianjun, Yiguo Hu, Jianhong Lin, et al.. (2015). Targeting the miR-221–222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma. Cancer Research. 75(20). 4384–4397. 72 indexed citations
15.
Cirstea, Diana, Loredana Santo, Teru Hideshima, et al.. (2014). Delineating the mTOR Kinase Pathway Using a Dual TORC1/2 Inhibitor, AZD8055, in Multiple Myeloma. Molecular Cancer Therapeutics. 13(11). 2489–2500. 24 indexed citations
16.
Hu, Yiguo. (2014). Acute Lymphoblastic Leukemia: Genetic Events and Molecular Signatures. American Journal of Biomedical Sciences. 238–253.
17.
Cirstea, Diana, Teru Hideshima, Loredana Santo, et al.. (2013). Small-molecule multi-targeted kinase inhibitor RGB-286638 triggers P53-dependent and -independent anti-multiple myeloma activity through inhibition of transcriptional CDKs. Leukemia. 27(12). 2366–2375. 47 indexed citations
18.
Fabre, Claire, Naoya Mimura, Kathryn Bobb, et al.. (2012). Dual Inhibition of Canonical and Noncanonical NF-κB Pathways Demonstrates Significant Antitumor Activities in Multiple Myeloma. Clinical Cancer Research. 18(17). 4669–4681. 66 indexed citations
19.
Sullivan, Con, Yaoyu Chen, Yi Shan, et al.. (2011). Functional Ramifications for the Loss of P-Selectin Expression on Hematopoietic and Leukemic Stem Cells. PLoS ONE. 6(10). e26246–e26246. 19 indexed citations
20.
Hu, Yiguo, Y Chen, L. Douglas, & Shuang Li. (2008). β-Catenin is essential for survival of leukemic stem cells insensitive to kinase inhibition in mice with BCR-ABL-induced chronic myeloid leukemia. Leukemia. 23(1). 109–116. 148 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026